BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH81786FSA
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

BioInvent International AB (BINV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioInvent International AB (BioInvent) focuses on the discovery and development of antibody drugs for the treatment of cancer. The company uses n-CoDeR, its inhouse platform for developing immuno-oncology drugs. n-CoDeR is an antibody library used for the rapid selection, screening and identification of antibodies. The company's pipeline portfolio comprises THR-317, an antibody to treat patients with diabetic macular edema; BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma and TB-403 being developed for the treatment of medulloblastoma. The company partners with several leading pharmaceutical companies including Daiichi Sankyo, Bayer Pharma and Mitsubishi Tanabe Pharma for the co-development of its drug candidates. BioInvent is headquartered in Lund, Sweden.

BioInvent International AB Key Recent Developments

Jul 09,2018: The Japanese patent office intends to grant BioInvent patent relevant to its F.I.R.S.T. platform

Apr 12,2018: BioInvent recruits Martin Welschof as new CEO

Jan 30,2018: BioInvent Reports Net Sales Of SEK 45 Million In 2017

Oct 24,2017: The CEO of BioInvent Michael Oredsson will resign at the end of the year

Jul 26,2017: BioInvent Interim Report 1 January-30 June 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

BioInvent International AB-Key Facts 5

BioInvent International AB-Key Employees 6

BioInvent International AB-Key Employee Biographies 7

BioInvent International AB-Major Products and Services 8

BioInvent International AB-History 9

BioInvent International AB-Company Statement 13

BioInvent International AB-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

BioInvent International AB-Business Description 16

BioInvent International AB-Corporate Strategy 17

BioInvent International AB-SWOT Analysis 18

SWOT Analysis-Overview 18

BioInvent International AB-Strengths 18

BioInvent International AB-Weaknesses 19

BioInvent International AB-Opportunities 20

BioInvent International AB-Threats 21

BioInvent International AB-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

BioInvent International AB, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Jul 09, 2018: The Japanese patent office intends to grant BioInvent patent relevant to its F.I.R.S.T. platform 32

Apr 12, 2018: BioInvent recruits Martin Welschof as new CEO 33

Oct 24, 2017: The CEO of BioInvent Michael Oredsson will resign at the end of the year 34

Jul 26, 2017: BioInvent Interim Report 1 January-30 June 2017 35

May 17, 2017: BioInvent Interim Report 39

Section 6-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

BioInvent International AB, Performance Chart (2013-2017) 26

BioInvent International AB, Ratio Charts 28

BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

BioInvent International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

List of Tables

BioInvent International AB, Key Facts 5

BioInvent International AB, Key Employees 6

BioInvent International AB, Key Employee Biographies 7

BioInvent International AB, Major Products and Services 8

BioInvent International AB, History 9

BioInvent International AB, Subsidiaries 14

BioInvent International AB, Key Competitors 22

BioInvent International AB, Ratios based on current share price 23

BioInvent International AB, Annual Ratios 24

BioInvent International AB, Annual Ratios (Cont...1) 25

BioInvent International AB, Interim Ratios 27

BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

BioInvent International AB, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Ablynx NV

Amgen Inc

Bristol-Myers Squibb Co

Dyax Corp

Genentech Inc

Genmab A/S

Merck & Co Inc

MorphoSys AG

Pfizer Inc

Seattle Genetics Inc

BioInvent International AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com